Dominant protein interactions that influence the pathogenesis of conformational diseases

Journal of Clinical Investigation

Volumn 123, Issue 7, 2013, Pages 3124-3134

  Wright, Jordan ^a   Wang, Xiaofan ^a,b   Haataja, Leena ^a   Kellogg, Aaron P ^a   Lee, Jaemin ^a   Liu, Ming ^a   Arvan, Peter ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SECRETORY PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFORMATIONAL DISEASE; DIMERIZATION; ENDOPLASMIC RETICULUM STRESS; GENE PRODUCT; HETEROZYGOSITY; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN SECRETION; RECESSIVE INHERITANCE; STOICHIOMETRY;

ANIMALS; CONGENITAL HYPOTHYROIDISM; DIABETES MELLITUS, TYPE 1; HEK293 CELLS; HUMANS; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; MUTATION, MISSENSE; PROINSULIN; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEOSTASIS DEFICIENCIES; THYROGLOBULIN;

EID: 84879658402     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67260     Document Type: Article

References (60)

1. Aridor M, Hannan LA. Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic. 2000;1(11):836-851.
2. Kim PS, Arvan P. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev. 1998;19(2):173-202. (Pubitemid 29114290)
3. Dodson G, Steiner D. The role of assembly in insulin's biosynthesis. Curr Opin Struct Biol. 1998;8(2):189-194. (Pubitemid 28221050)
4. Liu M, et al. Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth. Trends Endocrinol Metab. 2010;21(11):652-659.
5. Liu M, et al. Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport. PLoS One. 2010;5(10):e13333.
6. Rajan S, et al. In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes. Am J Physiol Endocrinol Metab. 2010;298(3):E403-E410.
7. Arvan P, Di Jeso B. Thyroglobulin structure, function, and biosynthesis. In: Braverman LE, Utiger R, eds. The Thyroid. Philadelphia, Pennsylvania, USA: Lippincott Williams and Wilkins; 2004:77-95.
8. Kim PS, Arvan P. Folding and assembly of newly synthesized thyroglobulin occurs in a pre-Golgi compartment. J Biol Chem. 1991;266(19):12412-12418. (Pubitemid 21907109)
9. Lee J, Di Jeso B, Arvan P. The cholinesterase-like domain of thyrogobulin functions as an intramolecular chaperone. J Clin Invest. 2008;118(8):2950-2958.
10. Lee J, Wang X, Di Jeso B, Arvan P. The cholinesterase-like domain, essential in thyroglobulin trafficking for thyroid hormone synthesis, is required for protein dimerization. J Biol Chem. 2009;284(19):12752-12761.
11. Targovnik HM, Esperante SA, Rivolta CM. Genetics and phenomics of hypothyroidism and goiter due to thyroglobulin mutations. Mol Cell Endocrinol. 2010;322(1-2):44-55.
12. Kim PS, Hossain SA, Park YN, Lee I, Yoo SE, Arvan P. A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases. Proc Natl Acad Sci U S A. 1998;95(17):9909-9913.
13. Hishinuma A, Furudate S, Oh-Ishi M, Nagakubo N, Namatame T, Ieiri T. A novel missense mutation (G2320R) in thyroglobulin causes hypothyroidism in rdw rats. Endocrinology. 2000;141(11):4050-4055.
14. Kim PS, et al. A missense mutation G2320R in the thyroglobulin gene causes non-goitrous congenital primary hypothyroidism in the WIC-rdw rat. Mol Endocrinol. 2000;14(12):1944-1953. (Pubitemid 32055528)
15. Umezu M, Kagabu S, Jiang J, Sato E. Evaluation and characterization of congenital hypothyroidism in rdw dwarf rats. Lab Anim Sci. 1998;48(5):496-501.
16. Menon S, et al. Oxidoreductase interactions include a role for ERp72 engagement with mutant thyroglobulin from the rdw/rdw rat dwarf. J Biol Chem. 2007;282(9):6183-6191. (Pubitemid 47100898)
17. Wang X, et al. Cis and trans actions of the cholinesterase-like domain within the thyroglobulin dimer. J Biol Chem. 2010;285(23):17564-17573.
18. Hodish I, et al. Misfolded proinsulin affects bystander proinsulin in neonatal diabetes. J Biol Chem. 2010;285(1):685-694.
19. Gupta S, McGrath B, Cavener DR. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes. 2010;59(8):1937-1947.
20. Haataja L, et al. Proinsulin intermolecular interactions during secretory trafficking in pancreatic β cells. J Biol Chem. 2013;288(3):1896-1906.
21. Fogelfeld L, Harel G, Beamer WG, Schneider AB. Low-molecular-weight iodoproteins in the congenital goiters of cog/cog mice. Thyroid. 1992;2(4):329-335. (Pubitemid 23054193)
22. Hodish I, et al. In vivo misfolding of proinsulin below the threshold of frank diabetes. Diabetes. 2011;60(8):2092-2101.
23. Orci L, Ravazzola M, Amherdt M, Madsen O, Vassalli JD. Direct identification of prohormone conversion site in insulin-secreting cells. Cell. 1985;42(2):671-681.
24. Schuit FC, In't Veld PA, Pipeleers DG. Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic β cells. Proc Natl Acad Sci U S A. 1988;85(11):3865-3869.
25. Kiekens R, In 't Veld P, Mahler T, Schuit F, Van De Winkel M, Pipeleers D. Differences in glucose recognition by individual rat pancreatic B cells are associated with intercellular differences in glucose-induced biosynthetic activity. J Clin Invest. 1992;89(1):117-125.
26. Nehls S, et al. Dynamics and retention of misfolded proteins in native ER membranes. Nat Cell Biol. 2000;2(5):288-295.
27. Guerriero CJ, Brodsky JL. The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiol Rev. 2012;92(2):537-576.
28. Hulleman JD, Balch WE, Kelly JW. Translational attenuation differentially alters the fate of disease-associated fibulin proteins. FASEB J. 2012;26(11):4548-4560.
29. Yu T, Chung C, Shen D, Xu H, Lieberman AP. Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts. Hum Mol Genet. 2012;21(14):3205-3214.
30. Wang F, Chou A, Segatori L. Lacidipine remodels protein folding and Ca 2+ homeostasis in Gaucher's disease fibroblasts: a mechanism to rescue mutant glucocerebrosidase. Chem Biol. 2011;18(6):766-776.
31. Yu T, Chung C, Shen D, Xu H, Lieberman AP. Ryanodine receptor antagonists adapt NPC1 proteostasis to ameliorate lipid storage in Niemann-Pick type C disease fibroblasts. Hum Mol Genet. 2012;21(14):3205-3214.
32. Conn PM, Janovick JA. Drug development and the cellular quality control system. Trends Pharmacol Sci. 2009;30(5):228-233.
33. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008;319(5865):916-919. (Pubitemid 351263754)
34. Lukacs GL, Verkman AS. CFTR: folding, misfolding and correcting the ΔF508 conformational defect. Trends Mol Med. 2012;18(2):81-91.
35. Lu PD, et al. Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J. 2004;23(1):169-179. (Pubitemid 38165757)
36. Hurtley SM, Helenius A. Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol. 1989;5:277-307. (Pubitemid 19286686)
37. Bole DG, Hendershot LM, Kearney JF. Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting hybridomas. J Cell Biol. 1986;102(5):1558-1566. (Pubitemid 16078740)
38. Doms RW. Oligomerization and protein transport. Methods Enzymol. 1990;191:841-854.
39. Leitzgen K, Knittler MR, Haas IG. Assembly of immunoglobulin light chains as a prerequisite for secretion. A model for oligomerization-dependent subunit folding. J Biol Chem. 1997;272(5):3117-3123. (Pubitemid 27053369)
40. Kerem A, Kronman C, Bar-Nun S, Shafferman A, Velan B. Interrelations between assembly and secretion of recombinant human acetylcholinesterase. J Biol Chem. 1993;268(1):180-184. (Pubitemid 23021302)
41. Reddy PS, Corley RB. Assembly, sorting, and exit of oligomeric proteins from the endoplasmic reticulum. Bioessays. 1998;20(7):546-554. (Pubitemid 28362300)
42. Anelli T, et al. Thiol-mediated protein retention in the endoplasmic reticulum: the role of ERp44. EMBO J. 2003;22(19):5015-5022. (Pubitemid 37222022)
43. Kim P, Bole D, Arvan P. Transient aggregation of nascent thyroglobulin in the endoplasmic reticulum: relationship to the molecular chaperone, BiP. J Cell Biol. 1992;118(3):541-549.
44. Lodish HF, Kong N, Wikstrom L. Calcium is required for folding of newly made subunits of the asialoglycoprotein receptor within the endoplasmic reticulum. J Biol Chem. 1992;267(18):12753-12760.
45. De Jaco A, et al. A mutation linked with autism reveals a common mechanism of endoplasmic reticulum retention for the alpha,beta-hydrolase fold protein family. J Biol Chem. 2006;281(14):9667-9676. (Pubitemid 43864685)
46. Hahn MK, Robertson D, Blakely RD. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J Neurosci. 2003;23(11):4470-4478. (Pubitemid 36706177)
47. Cordat E, et al. Dominant and recessive distal renal tubular acidosis mutations of kidney anion exchanger 1 induce distinct trafficking defects in MDCK cells. Traffic. 2006;7(2):117-128.
48. Mendes HF, Cheetham ME. Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa. Hum Mol Genet. 2008;17(19):3043-3054.
49. Kagan A, Yu Z, Fishman GI, McDonald TV. The dominant negative LQT2 mutation A561V reduces wild-type HERG expression. J Biol Chem. 2000;275(15):11241-11248. (Pubitemid 30212770)
50. Butler DC, McLear JA, Messer A. Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins. Prog Neurobiol. 2012;97(2):190-204.
51. Li C, Xiao P, Gray SJ, Weinberg MS, Samulski RJ. Combination therapy utilizing shRNA knockdown and an optimized resistant transgene for rescue of diseases caused by misfolded proteins. Proc Natl Acad Sci U S A. 2011;108(34):14258-14263.
52. Sandefur CI, Schnell S. A model of threshold behavior reveals rescue mechanisms of bystander proteins in conformational diseases. Biophys J. 2011;100(8):1864-1873.
53. Navarro D, Qadri I, Pereira L. A mutation in the ectodomain of herpes simplex virus 1 glycoprotein B causes defective processing and retention in the endoplasmic reticulum. Virology. 1991;184(1):253-264.
54. Marquardt T, Helenius A. Misfolding and aggregation of newly synthesized proteins in the endoplasmic reticulum. J Cell Biol. 1992;117(3):505-513.
55. Kittanakom S, Cordat E, Akkarapatumwong V, Yenchitsomanus PT, Reithmeier RA. Trafficking defects of a novel autosomal recessive distal renal tubular acidosis mutant (S773P) of the human kidney anion exchanger (kAE1). J Biol Chem. 2004;279(39):40960-40971. (Pubitemid 39287696)
56. Wang J, Chen Y, Yuan Q, Tang W, Zhang X, Osei K. Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic beta-cells. PLoS One. 2011;6(4):e19446.
57. Liu M, Li Y, Cavener D, Arvan P. Proinsulin disulfide maturation and misfolding in the endoplasmic reticulum. J Biol Chem. 2005;280(14):13209-13212. (Pubitemid 40517203)
58. Laybutt DR, et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia. 2007;50(4):752-763. (Pubitemid 46355827)
59. Scheuner D, Kaufman RJ. The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev. 2008;29(3):317-333. (Pubitemid 351679702)
60. Ledent C, Parmentier M, Vassart G. Tissue-specific expression and methylation of a thyroglobulin-chloramphenicol acetyltransferase fusion gene in transgenic mice. Proc Natl Acad Sci U S A. 1990;87(16):6176-6180.